Cargando…

Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development

Bio-layer interferometry (BLI) real-time, label-free technology has greatly contributed to advances in vaccine research and development. BLI Octet platforms offer high-throughput, ease of use, reliability, and high precision analysis when compared with common labeling techniques. Many different stra...

Descripción completa

Detalles Bibliográficos
Autor principal: Petersen, Rejane L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746772/
https://www.ncbi.nlm.nih.gov/pubmed/29088096
http://dx.doi.org/10.3390/bios7040049
_version_ 1783289164285870080
author Petersen, Rejane L.
author_facet Petersen, Rejane L.
author_sort Petersen, Rejane L.
collection PubMed
description Bio-layer interferometry (BLI) real-time, label-free technology has greatly contributed to advances in vaccine research and development. BLI Octet platforms offer high-throughput, ease of use, reliability, and high precision analysis when compared with common labeling techniques. Many different strategies have been used to immobilize the pathogen or host molecules on BLI biosensors for real-time kinetics and affinity analysis, quantification, or high-throughput titer. These strategies can be used in multiple applications and shed light onto the structural and functional aspects molecules play during pathogen-host interactions. They also provide crucial information on how to achieve protection. This review summarizes some key BLI strategies used in human vaccine research and development.
format Online
Article
Text
id pubmed-5746772
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57467722018-01-03 Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development Petersen, Rejane L. Biosensors (Basel) Review Bio-layer interferometry (BLI) real-time, label-free technology has greatly contributed to advances in vaccine research and development. BLI Octet platforms offer high-throughput, ease of use, reliability, and high precision analysis when compared with common labeling techniques. Many different strategies have been used to immobilize the pathogen or host molecules on BLI biosensors for real-time kinetics and affinity analysis, quantification, or high-throughput titer. These strategies can be used in multiple applications and shed light onto the structural and functional aspects molecules play during pathogen-host interactions. They also provide crucial information on how to achieve protection. This review summarizes some key BLI strategies used in human vaccine research and development. MDPI 2017-10-31 /pmc/articles/PMC5746772/ /pubmed/29088096 http://dx.doi.org/10.3390/bios7040049 Text en © 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Petersen, Rejane L.
Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development
title Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development
title_full Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development
title_fullStr Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development
title_full_unstemmed Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development
title_short Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development
title_sort strategies using bio-layer interferometry biosensor technology for vaccine research and development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746772/
https://www.ncbi.nlm.nih.gov/pubmed/29088096
http://dx.doi.org/10.3390/bios7040049
work_keys_str_mv AT petersenrejanel strategiesusingbiolayerinterferometrybiosensortechnologyforvaccineresearchanddevelopment